RLAY Competitors & Alternatives
Compare Relay Therapeutics Inc with similar stocks in the same industry
Biotechnology
RLAY
Main Stock$12.78
Tradestie Score
54
Market Cap
$917.23M
Revenue Growth
-0.6%
Analyst Upside
+64.3%
Top Competitors
231 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CPRX
Catalyst Pharmaceutical Inc.
|
$31.16
|
$2.56B | 18.0 | 60 | Compare |
|
CDTX
Cidara Therapeutics, Inc.
|
$221.38
|
$2.44B | - | 57 | Compare |
|
BEAM
Beam Therapeutics Inc. Common Stock
|
$29.53
|
$2.44B | - | 58 | Compare |
|
TARS
Tarsus Pharmaceuticals, Inc. Common Stock
|
$65.18
|
$2.42B | - | 57 | Compare |
|
BLTE
Belite Bio, Inc American Depositary Shares
|
$149.95
|
$2.41B | - | 56 | Compare |
|
IDYA
IDEAYA Biosciences, Inc. Common Stock
|
$28.84
|
$2.40B | - | 55 | Compare |
|
FOLD
Amicus Therapeutics, Inc
|
$14.49
|
$2.38B | - | 60 | Compare |
|
ARQT
Arcutis Biotherapeutics, Inc. Common Stock
|
$21.57
|
$2.37B | - | 57 | Compare |
|
APGE
Apogee Therapeutics, Inc. Common Stock
|
$83.91
|
$2.35B | - | 54 | Compare |
|
IBRX
ImmunityBio, Inc. Common Stock
|
$8.15
|
$2.34B | - | 60 | Compare |
More RLAY Analysis
Data updated: May 14, 2026 | Industry: Biotechnology (SIC 2836)
231 stocks in this industry